Literature DB >> 32458694

Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.

Xiaoming Guo1, Yueli Zhu2, Yuan Hong1.   

Abstract

Entities:  

Keywords:  global health; humans; hypertension; pandemics; renin-angiotensin system

Mesh：

Substances：

Year:  2020        PMID： 32458694     DOI： 10.1161/HYPERTENSIONAHA.120.15572

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  53 in total

1.  Epidemiology and risk factors related to severity of clinical manifestations of COVID-19 in outpatients: A retrospective study in Haiti.

Authors:  Mentor Ali Ber Lucien; Katilla Pierre; Gladzdin Jean-Denis; Jonas Rigodon; Caitlin M Worrell; Alexia Couture; Aspen Flynn; Mauricio Cerpa Calderon; Luis Felipe Codina; Andrea S Vicari; Samson Marseille; Koama T Jean Baptiste; Bernadette Fouche; Gerard Joseph; Ito Journel; Kenold Rendel; Yoran Grant-Greene; Nadia P Jean-Charles; Donald Lafontant; Senou Amouzou; Wilnique Pierre; Marie Greta Roy Clement; Stanley Juin; Jacques Boncy; Patrick Dely
Journal:  PLoS One       Date:  2022-09-21       Impact factor: 3.752

2.  Association of outpatient use of renin-angiotensin-aldosterone system blockers on outcomes of acute respiratory illness during the COVID-19 pandemic: a cohort study.

Authors:  Molly Moore Jeffery; Lucas Oliveira J E Silva; Fernanda Bellolio; Vesna D Garovic; Timothy M Dempsey; Andrew Limper; Nathan W Cummins
Journal:  BMJ Open       Date:  2022-07-06       Impact factor: 3.006

3.  Angiotensin II Promotes SARS-CoV-2 Infection via Upregulation of ACE2 in Human Bronchial Cells.

Authors:  Ilaria Caputo; Brasilina Caroccia; Ilaria Frasson; Elena Poggio; Stefania Zamberlan; Margherita Morpurgo; Teresa M Seccia; Tito Calì; Marisa Brini; Sara N Richter; Gian Paolo Rossi
Journal:  Int J Mol Sci       Date:  2022-05-04       Impact factor: 6.208

4.  Plasma Angiotensin II Is Increased in Critical Coronavirus Disease 2019.

Authors:  Rafael L Camargo; Bruna Bombassaro; Milena Monfort-Pires; Eli Mansour; Andre C Palma; Luciana C Ribeiro; Raisa G Ulaf; Ana Flavia Bernardes; Thyago A Nunes; Marcus V Agrela; Rachel P Dertkigil; Sergio S Dertkigil; Eliana P Araujo; Wilson Nadruz; Maria Luiza Moretti; Licio A Velloso; Andrei C Sposito
Journal:  Front Cardiovasc Med       Date:  2022-06-24

Review 5.  p53/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics).

Authors:  Daniela Milani; Lorenzo Caruso; Enrico Zauli; Adi Mohammed Al Owaifeer; Paola Secchiero; Giorgio Zauli; Donato Gemmati; Veronica Tisato
Journal:  Front Pharmacol       Date:  2022-05-27       Impact factor: 5.988

Review 6.  Renin-Angiotensin Aldosterone System Inhibitors and COVID-19: A Systematic Review and Meta-Analysis Revealing Critical Bias Across a Body of Observational Research.

Authors:  Jordan Loader; Frances C Taylor; Erik Lampa; Johan Sundström
Journal:  J Am Heart Assoc       Date:  2022-05-27       Impact factor: 6.106

Review 7.  Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges.

Authors:  Krishna Sriram; Rohit Loomba; Paul A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-17       Impact factor: 11.205

8.  Chronic use of renin-angiotensin-aldosterone system blockers and mortality in COVID-19: A multicenter prospective cohort and literature review.

Authors:  Nathalie Gault; Marina Esposito-Farèse; Matthieu Revest; Jocelyn Inamo; André Cabié; Élisabeth Polard; Jean-Sébastien Hulot; Jade Ghosn; Catherine Chirouze; Laurène Deconinck; Jean-Luc Diehl; Julien Poissy; Olivier Epaulard; Benjamin Lefèvre; Lionel Piroth; Etienne De Montmollin; Eric Oziol; Manuel Etienne; Cédric Laouénan; Patrick Rossignol; Dominique Costagliola; Emmanuelle Vidal-Petiot
Journal:  Fundam Clin Pharmacol       Date:  2021-05-16       Impact factor: 2.747

Review 9.  Endothelial Dysfunction and SARS-CoV-2 Infection: Association and Therapeutic Strategies.

Authors:  Hai Deng; Ting-Xuan Tang; Deng Chen; Liang-Sheng Tang; Xiang-Ping Yang; Zhao-Hui Tang
Journal:  Pathogens       Date:  2021-05-11

Review 10.  COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course.

Authors:  Cyril P Landstra; Eelco J P de Koning
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-17       Impact factor: 5.555
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.